Molecular typing of adult acute myeloid leukaemia: Significance of translocations, tandem duplications, methylation, and selective gene expression profiling

British Journal of Haematology

Volumn 131, Issue 4, 2005, Pages 457-467

  Olesen, Lene Hyldahl ^a   Aggerholm, Anni ^a   Andersen, Bodil Lind ^a   Nyvold, Charlotte Guldborg ^a   Guldberg, Per ^b   Nørgaard, Jan Maxwell ^a   Hokland, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Acute leukaemia; Gene expression; Molecular analysis; Prognostic factors

Indexed keywords

AMSACRINE; ANTHRACYCLINE; CASPASE 3; CYTARABINE; ESTROGEN RECEPTOR; ETOPOSIDE; FLT3 LIGAND; MIXED LINEAGE LEUKEMIA PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAX; PROTEIN P15; UVOMORULIN; CD135 ANTIGEN; DNA; FLT3 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW; CANCER CHEMOTHERAPY; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL OBSERVATION; CONTROLLED STUDY; DNA METHYLATION; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; STATISTICAL SIGNIFICANCE; TANDEM REPEAT; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; ACUTE DISEASE; GENE; GENE TRANSLOCATION; GENETICS; METABOLISM; MIDDLE AGED; MYELOID LEUKEMIA; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; DNA, NEOPLASM; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; GENES, MDR; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TANDEM REPEAT SEQUENCES; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 33644798659     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05791.x     Document Type: Article

References (53)

1. Abu-Duhier F.M. Goodeve A.C. Wilson G.A. Gari M.A. Peake I.R. Rees D.C. Vandenberghe E.A. Winship P.R. Reilly J.T. ( 2000) FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. British Journal of Haematology, 111, 190 195.
2. Aggerholm A. Guldberg P. Hokland M. Hokland P. ( 1999) Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukaemia. Cancer Research, 59, 436 441.
3. Appelbaum F.R. Rowe J.M. Radich J. Dick J.E. ( 2001) Acute myeloid leukemia. Hematology (American Society Hematology. Educational Program), 62 86 Kwong Y.L. ( 2003) Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. British Journal of Haematology, 120, 1062 1065.
4. Bartkova J. Lukas J. Bartek J. ( 1997) Aberrations of the G1- and G1/S-regulating genes in human cancer. Progress in Cell Cycle Research, 3, 211 220.
5. Beillard E. Pallisgaard N. van der Velden V.H. Bi W. Dee R. van der Schoot E. Delabesse E. Macintyre E. Gottardi E. Saglio G. Watzinger F. Lion T. van Dongen J.J. Hokland P. Gabert J. ( 2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia, 17, 2474 2486.
6. Borst P. Evers R. Kool M. Wijnholds J. ( 2000) A family of drug transporters: the multidrug resistance-associated proteins. Journal of the National Cancer Institute, 92, 1295 1302.
7. Chauncey T.R. ( 2001) Drug resistance mechanisms in acute leukemia. Current Opinion in Oncology, 13, 21 26.
8. Ekmekci C.G. Gutierrez M.I. Siraj A.K. Ozbek U. Bhatia K. ( 2004) Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. American Journal of Hematology, 77, 233 240.
9. Esteller M. ( 2003) Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clinical Immunology, 109, 80 88.
10. Esteller M. Fraga M.F. Paz M.F. Campo E. Colomer D. Novo F.J. Calasanz M.J. Galm O. Guo M. Benitez J. Herman J.G. ( 2002) Cancer epigenetics and methylation. Science, 297, 1807 1808 discussion 1807 1808.
11. Estrov Z. Thall P.F. Talpaz M. Estey E.H. Kantarjian H.M. Andreeff M. Harris D. Van Q. Walterscheid M. Kornblau S.M. ( 1998) Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood, 92, 3090 3097.
12. Filipits M. Stranzl T. Pohl G. Heinzl H. Jager U. Geissler K. Fonatsch C. Haas O.A. Lechner K. Pirker R. ( 2000) Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia, 14, 68 76.
13. Gajate C. Santos-Beneit A.M. Macho A. Lazaro M. Hernandez-De Rojas A. Modolell M. Munoz E. Mollinedo F. ( 2000) Involvement of mitochondria and caspase-3 in ET-18-OCH(3)-induced apoptosis of human leukemic cells. International Journal of Cancer, 86, 208 218.
14. Grimwade D. ( 2001) The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Practice and Research. Clinical Haematology, 14, 497 529.
15. Grimwade D. Walker H. Oliver F. Wheatley K. Harrison C. Harrison G. Rees J. Hann I. Stevens R. Burnett A. Goldstone A. ( 1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 92, 2322 2333.
16. Herman J.G. Civin C.I. Issa J.P. Collector M.I. Sharkis S.J. Baylin S.B. ( 1997) Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Research, 57, 837 841.
17. Hunault M. Zhou D. Delmer A. Ramond S. Viguie F. Cadiou M. Perrot J.Y. Levy V. Rio B. Cymbalista F. Zittoun R. Marie J.P. ( 1997) Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment. Annals of Hematology, 74, 65 71.
18. Iijima N. Miyamura K. Itou T. Tanimoto M. Sobue R. Saito H. ( 1997) Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy. Blood, 90, 4901 4909.
19. Mitelman F.P. ( 1995) An International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
20. Issa J.P. Zehnbauer B.A. Civin C.I. Collector M.I. Sharkis S.J. Davidson N.E. Kaufmann S.H. Baylin S.B. ( 1996) The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Research, 56, 973 977.
21. Karakas T. Maurer U. Weidmann E. Miething C.C. Hoelzer D. Bergmann L. ( 1998) High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Annals of Oncology, 9, 159 165.
22. Knudson A.G. ( 1996) Hereditary cancer: two hits revisited. Journal of Cancer Research and Clinical Oncology, 122, 135 140.
23. Kohler T. Schill C. Deininger M.W. Krahl R. Borchert S. Hasenclever D. Leiblein S. Wagner O. Niederwieser D. ( 2002) High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia, 16, 22 29.
24. Kottaridis P.D. Gale R.E. Frew M.E. Harrison G. Langabeer S.E. Belton A.A. Walker H. Wheatley K. Bowen D.T. Burnett A.K. Goldstone A.H. Linch D.C. ( 2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752 1759.
25. Leith C.P. Kopecky K.J. Chen I.M. Eijdems L. Slovak M.L. McConnell T.S. Head D.R. Weick J. Grever M.R. Appelbaum F.R. Willman C.L. ( 1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 94, 1086 1099.
26. Li Q. Kopecky K.J. Mohan A. Willman C.L. Appelbaum F.R. Weick J.K. Issa J.P. ( 1999) Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia. Clinical Cancer Research, 5, 1077 1084.
27. Löwenberg B. ( 2001) Prognostic factors in acute myeloid leukaemia. Best Practice and Reserch. Clinical Haematology, 14, 65 75.
28. Mano H. ( 2004) Stratification of acute myeloid leukemia based on gene expression profiles. International Journal of Hematology, 80, 389 394.
29. Mareel M. Bracke M. Van Roy F. ( 1995) Cancer metastasis: negative regulation by an invasion-suppressor complex. Cancer Detection and Prevention, 19, 451 464.
30. Melki J.R. Vincent P.C. Clark S.J. ( 1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Research, 59, 3730 3740.
31. Meshinchi S. Woods W.G. Stirewalt D.L. Sweetser D.A. Buckley J.D. Tjoa T.K. Bernstein I.D. Radich J.P. ( 2001) Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood, 97, 89 94.
32. Nakayama M. Wada M. Harada T. Nagayama J. Kusaba H. Ohshima K. Kozuru M. Komatsu H. Ueda R. Kuwano M. ( 1998) Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood, 92, 4296 4307.
33. Norgaard J.M. Bukh A. Langkjer S.T. Clausen N. Palshof T. Hokland P. ( 1998) MDR1 gene expression and drug resistance of AML cells. British Journal of Haematology, 100, 534 540.
34. Norgaard J.M. Olesen L.H. Hokland P. ( 2004) Changing picture of cellular drug resistance in human leukemia. Critical Reviews in Oncology/hematology, 50, 39 49.
35. Olesen L.H. Norgaard J.M. Pallisgaard N. Bukh A. Hokland P. ( 2003) Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia. European Journal of Haematology, 70, 296 303.
36. Olesen L.H. Clausen N. Dimitrijevic A. Kerndrup G. Kjeldsen E. Hokland P. ( 2004) Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. British Journal of Haematology, 127, 59 66.
37. Ong Y.L. McMullin M.F. Bailie K.E. Lappin T.R. Jones F.G. Irvine A.E. ( 2000) High bax expression is a good prognostic indicator in acute myeloid leukaemia. British Journal of Haematology, 111, 182 189.
38. Pallisgaard N. Hokland P. Riishoj D.C. Pedersen B. Jorgensen P. ( 1998) Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood, 92, 574 588.
39. Parker J.E. Mufti G.J. Rasool F. Mijovic A. Devereux S. Pagliuca A. ( 2000) The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood, 96, 3932 3938.
40. Reilly J.T. ( 2005) Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis British Journal of Haematology, 128, 18 34.
41. Rowley J.D. ( 1999) The role of chromosome translocations in leukemogenesis. Seminars in Hematology, 36, 59 72.
42. Schimmer A.D. Pedersen I.M. Kitada S. Eksioglu-Demiralp E. Minden M.D. Pinto R. Mah K. Andreeff M. Kim Y. Suh W.S. Reed J.C. ( 2003) Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Research, 63, 1242 1248.
43. Schnittger S. Schoch C. Dugas M. Kern W. Staib P. Wuchter C. Loffler H. Sauerland C.M. Serve H. Buchner T. Haferlach T. Hiddemann W. ( 2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, 59 66.
44. Sonneveld P. List A.F. ( 2001) Chemotherapy resistance in acute myeloid leukaemia. Best Practice and Research. Clinical Haematology, 14, 211 233.
45. Taki T. Ida K. Bessho F. Hanada R. Kikuchi A. Yamamoto K. Sako M. Tsuchida M. Seto M. Ueda R. Hayashi Y. ( 1996) Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Leukemia, 10, 1303 1307.
46. Tenen D.G. ( 2003) Disruption of differentiation in human cancer: AML shows the way. Nature Reviews. Cancer, 3, 89 101.
47. Vey N. Mozziconacci M.J. Groulet-Martinec A. Debono S. Finetti P. Carbuccia N. Beillard E. Devilard E. Arnoulet C. Coso D. Sainty D. Xerri L. Stoppa A.M. Lafage-Pochitaloff M. Nguyen C. Houlgatte R. Blaise D. Maraninchi D. Birg F. Birnbaum D. Bertucci F. ( 2004) Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling. Oncogene, 23, 9381 9391.
48. Willman C.L. ( 1997) The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Seminars in Hematology, 34, 25 33.
49. Worm J. Aggerholm A. Guldberg P. ( 2001) In-tube DNA methylation profiling by fluorescence melting curve analysis. Clinical Chemistry, 47, 1183 1189.
50. Wu Q. Guo X. Fan H. Zhou T. Tan G. Guo Q. Chen P. Zhang X. Luo G. Xu M. ( 2000) P15(INK4B) gene methylation in malignant hematopoietic diseases. Zhonghua Xue Ye Xue Za Zhi, 21, 644 646.
51. Wuchter C. Leonid K. Ruppert V. Schrappe M. Buchner T. Schoch C. Haferlach T. Harbott J. Ratei R. Dorken B. Ludwig W.D. ( 2000) Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica, 85, 711 721.
52. Yuan Y. Zhou L. Miyamoto T. Iwasaki H. Harakawa N. Hetherington C.J. Burel S.A. Lagasse E. Weissman I.L. Akashi K. Zhang D.E. ( 2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proceedings of the National Academy of Sciences of the United States of America, 98, 10398 10403.
53. Yunis J.J. ( 1981) New chromosome techniques in the study of human neoplasia. Human Pathology, 12, 540 549.